Active secondary progressive multiple sclerosis treatment with a selective sphingosine-1-phosphate receptor modulator

被引：0
|
作者：
Michnova, Katerina [1 ]
Horakova, Dana [2 ]
机构：
[1] Care Comm Sro, Prague, Czech Republic
[2] 1 LF UK VFN Praze, Neurol Klin, Prague, Czech Republic
来源：
CESKA A SLOVENSKA NEUROLOGIE A NEUROCHIRURGIE | 2020年 / 83卷 / 06期
关键词：
INTERFERON BETA-1B; MS;
D O I：
暂无
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
引用
收藏
页码：683 / 684
页数：2
相关论文
共 50 条
  • [21] The sphingosine-1-phosphate receptor: A novel therapeutic target for multiple sclerosis and other autoimmune diseases
    Mao-Draayer, Yang
    Sarazin, Jeffrey
    Fox, David
    Schiopu, Elena
    [J]. CLINICAL IMMUNOLOGY, 2017, 175 : 10 - 15
  • [22] Sphingosine-1-phosphate receptor 2
    Adada, Mohamad
    Canals, Daniel
    Hannun, Yusuf A.
    Obeid, Lina M.
    [J]. FEBS JOURNAL, 2013, 280 (24) : 6354 - 6366
  • [23] Sphingosine-1-phosphate receptor 3 signaling is a critical modulator of stroke outcome
    Matuskova, Hana
    Matthes, Frank
    Petzold, Gabor
    Meissner, Anja
    [J]. JOURNAL OF VASCULAR RESEARCH, 2023, 60 (SUPP1) : 19 - 19
  • [24] Ponesimod, mono-selective sphingosine-1-phosphate receptor 1 modulator enhances oligodendrocyte precursor cell differentiation
    Willems, E.
    Schepers, M.
    Ait-Tihyaty, M.
    Vanmierlo, T.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (3_SUPPL) : 351 - 352
  • [25] Piperazinyl-oxadiazoles as selective sphingosine-1-phosphate receptor agonists
    Horan, Joshua C.
    Sanyal, Sulagna
    Choi, Younggi
    Hill-Drzewi, Melissa
    Patnaude, Lori
    Anderson, Shawn
    Fogal, Steve
    Mao, Can
    Cook, Brian N.
    Gueneva-Boucheva, Kristina
    Fisher, Michael B.
    Hickey, Eugene
    Pack, Edward
    Bannen, Lynne C.
    Chan, Diva S.
    Mac, Morrison B.
    Ng, Stephanie M.
    Wang, Yong
    Xu, Wei
    Modis, Louise K.
    Lemieux, Rene M.
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2014, 24 (20) : 4807 - 4811
  • [26] Results From the First-in-Human Study With Ozanimod, a Novel, Selective Sphingosine-1-Phosphate Receptor Modulator
    Tran, Jonathan Q.
    Hartung, Jeffrey P.
    Peach, Robert J.
    Boehm, Marcus F.
    Rosen, Hugh
    Smith, Heather
    Brooks, Jennifer L.
    Timony, Gregg A.
    Olson, Allan D.
    Gujrathi, Sheila
    Frohna, Paul A.
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 2017, 57 (08): : 988 - 996
  • [27] Brain sphingosine-1-phosphate receptors: Implication for FTY720 in the treatment of multiple sclerosis
    Dev, Kumlesh K.
    Mullershausen, Florian
    Mattes, Henri
    Kuhn, Rainer R.
    Bilbe, Graeme
    Hoyer, Daniel
    Mir, Anis
    [J]. PHARMACOLOGY & THERAPEUTICS, 2008, 117 (01) : 77 - 93
  • [28] Sphingosine 1-Phosphate Receptor 1 as a Useful Target for Treatment of Multiple Sclerosis
    Chiba, Kenji
    Adachi, Kunitomo
    [J]. PHARMACEUTICALS, 2012, 5 (05): : 514 - 528
  • [29] Selective Modulation of Sphingosine-1-Phosphate Receptor-1 And-5 In Multiple Sclerosis: Preclinical and Clinical Experience with ONO-4641
    Saida, T.
    Scaramozza, M.
    Boschert, U.
    Due, B.
    Fischer, T. Z.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2014, 20 (07) : 929 - 929
  • [30] The Sphingosine-1-Phosphate Receptor Modulator Fingolimod Aggravates Murine Epidermolysis Bullosa Acquisita
    Thieme, Markus
    Bieber, Katja
    Sezin, Tanya
    Wannick, Melanie
    Gupta, Yask
    Kalies, Kathrin
    Ludwig, Ralf J.
    Mousavi, Sadegh
    Zillikens, Detlef
    Sadik, Christian D.
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2019, 139 (11) : 2381 - +
12345